Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Prostatic Neoplasms × Lutetium-177 × Clear all

Phase

Status

Recruiting 4 Withdrawn 1 Terminated 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Carcinoma, Adenoid Cystic 1

Interventions

Prednisone 10 Magnetic Resonance Spectroscopy 8 Leuprolide 8 Docetaxel 8 bicalutamide 7 Radiotherapy 7 Biopsy 6 Abiraterone Acetate 6 gallium 68 PSMA-11 5 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5 Metformin 5 enzalutamide 4 Specimen Handling 4 Goserelin 4 radium Ra 223 dichloride 3 orteronel 3 apalutamide 3 Surveys and Questionnaires 3 Radiosurgery 3 Pioglitazone 3 Paclitaxel 3 Injections 3 Exercise 3 Brachytherapy 3 Androgen Antagonists 3 olaparib 2 niraparib 2 luprolide acetate gel depot 2 cabazitaxel 2 atezolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06881823 2025-12-29

NeoPSMA

Novartis

Phase 1/2 Withdrawn

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡